Literature DB >> 179502

Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests.

G R Skinner, C H Hartley, J E Whitney.   

Abstract

Type-specific antigens for herpes simplex virus type 1 and 2 were prepared by rigorous absorption of cell extracts with heterotypic immune sera. Type-specificity was demonstrated by immunodiffusion and complement-fixation tests against immune sera prepared in rabbits. Specific type 1 complement-fixing reactivity was detected in eleven of fifteen sera from Roman Catholic nuns and in two convalescent sera from patients with recurrent herpes labialis; these sera had been previously shown to contain neutralising and complement-fixing antibody to herpes simplex virus. Three of the non-reacting sera contained low or absent levels of type-common complement-fixing reactivity and other contained no type-specific neutralising antibody. With the exception of three "acute" sera, specific type 2 complement-fixing reactivity was detected in every convalescent or interim serum obtained from patients with a virologically-proven history of type 2 herpes virus infection. It is suggested that complement-fixation testing using these absorbed type-specific antigens preparations may provide a convenient and rapid method for the identification of type-specific antibody in human sera.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 179502     DOI: 10.1007/bf01317957

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  22 in total

1.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.

Authors:  I MACPHERSON; M STOKER
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

2.  Occurrence of herpes- and adenovirus antibodies in patients with carcinoma of the cervix uteri. Measurement of antibodies to herpesvirus hominis (types 1 and 2), cytomegalovirus, EB-virus, and adenovirus.

Authors:  B F Vestergaard; A Hornsleth; S N Pedersen
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

3.  Antibody to genital herpes simplex virus: association with cervical atypia and carcinoma in situ.

Authors:  L Aurelian; I Royston; H J Davis
Journal:  J Natl Cancer Inst       Date:  1970-09       Impact factor: 13.506

4.  Serological properties of thymidine kinase produced in cells infected with type 1 or type 2 herpes virus.

Authors:  M E Thouless
Journal:  J Gen Virol       Date:  1972-12       Impact factor: 3.891

5.  The separation of herpes virus-specific antigens by polyacrylamide gel electrophoresis.

Authors:  D H Watson
Journal:  J Gen Virol       Date:  1969-03       Impact factor: 3.891

6.  Genital herpetic infection. Association with cervical dysplasia and carcinoma.

Authors:  Z M Naib; A J Nahmias; W E Josey; J H Kramer
Journal:  Cancer       Date:  1969-04       Impact factor: 6.860

7.  Antibodies to Herpesvirus hominis types 1 and 2 in the rabbit.

Authors:  A J Nahmias; W R Dowdle; J H Kramer; C F Luce; S C Mansour
Journal:  J Immunol       Date:  1969-04       Impact factor: 5.422

8.  Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. IV. Dysplasia and carcinoma in situ.

Authors:  E Adam; R H Kaufman; J L Melnick; A H Levy; W E Rawls
Journal:  Am J Epidemiol       Date:  1973-08       Impact factor: 4.897

9.  Antibodies to type 1 and type 2 herpes virus in women with abnormal cervical cytology.

Authors:  G R Skinner; M E Thouless; J A Jordan
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-11

10.  Herpesvirus type 2: association with carcinoma of the cervix.

Authors:  W E Rawls; W A Tompkins; M E Figueroa; J L Melnick
Journal:  Science       Date:  1968-09-20       Impact factor: 47.728

View more
  5 in total

1.  Antibody reactivity with Skinner HSV vaccine.

Authors:  E M Muniu; J Durham; D Shariff; C E Hartley; A Fuller; J Melling; C Wiblin; G Wilkins; A Buchan; G R Skinner
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

2.  Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection.

Authors:  J Kahlon; F D Lakeman; M Ackermann; R J Whitley
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

3.  Type specificity and use of human sera for rapid typing of herpes simplex virus isolates by an indirect peroxidase-labeled antibody technique: a comparison with three other methods.

Authors:  G Gerna; J Ditmore; R W Chambers
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

4.  Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology: evidence towards pre-pubertal vaccination of sero-negative female subjects.

Authors:  G R Skinner; J E Whitney; C Hartley
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

5.  The relative infrequency and low levels of neutralising and immunoprecipitating antibody to herpes simplex viruses types 1 and 2 in patients with a history of recurrent herpes genitalis.

Authors:  C B Woodman; D Stocker; D Sugrue; M Desberbasques; C E Hartley; A Fuller; A Buchan; G R Skinner
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.